Winnergy Medical Public Company Limited
Winnergy Medical Public Company Limited engages in the distribution of medical and diagnostic equipment in Thailand. The company imports and distributes technology and diagnostic kits for cervical cancer screening, including cytology examinations using automatic slide preparation machines and testing for human papilloma virus, and colposcopes. It also offers equipment for testing blood quality an… Read more
Winnergy Medical Public Company Limited (WINMED) - Total Assets
Latest total assets as of September 2025: ฿1.10 Billion THB
Based on the latest financial reports, Winnergy Medical Public Company Limited (WINMED) holds total assets worth ฿1.10 Billion THB as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Winnergy Medical Public Company Limited - Total Assets Trend (2016–2024)
This chart illustrates how Winnergy Medical Public Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Winnergy Medical Public Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Winnergy Medical Public Company Limited's total assets of ฿1.10 Billion consist of 49.8% current assets and 50.2% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 2.1% |
| Accounts Receivable | ฿218.14 Million | 19.7% |
| Inventory | ฿116.74 Million | 10.6% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿37.75 Million | 3.4% |
| Goodwill | ฿0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Winnergy Medical Public Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Winnergy Medical Public Company Limited's current assets represent 49.8% of total assets in 2024, a decrease from 98.6% in 2016.
- Cash Position: Cash and equivalents constituted 2.1% of total assets in 2024, down from 8.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 19.7% of total assets.
Winnergy Medical Public Company Limited Competitors by Total Assets
Key competitors of Winnergy Medical Public Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Winnergy Medical Public Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Winnergy Medical Public Company Limited generates 0.59x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Winnergy Medical Public Company Limited generates $ 2.65 in net profit.
Winnergy Medical Public Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.79 | 2.11 | 1.08 |
| Quick Ratio | 1.28 | 1.69 | 0.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿243.21 Million | ฿ 248.88 Million | ฿ 19.08 Million |
Winnergy Medical Public Company Limited - Advanced Valuation Insights
This section examines the relationship between Winnergy Medical Public Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.58 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 13.1% |
| Total Assets | ฿1.11 Billion |
| Market Capitalization | $3.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values Winnergy Medical Public Company Limited's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Winnergy Medical Public Company Limited's assets grew by 13.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Winnergy Medical Public Company Limited (2016–2024)
The table below shows the annual total assets of Winnergy Medical Public Company Limited from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ฿1.11 Billion | +13.08% |
| 2023-12-31 | ฿977.88 Million | +15.28% |
| 2022-12-31 | ฿848.24 Million | +12.28% |
| 2021-12-31 | ฿755.46 Million | +53.52% |
| 2020-12-31 | ฿492.10 Million | +48.40% |
| 2019-12-31 | ฿331.60 Million | -5.72% |
| 2018-12-31 | ฿351.72 Million | +241.59% |
| 2017-12-31 | ฿102.97 Million | -32.90% |
| 2016-12-31 | ฿153.44 Million | -- |